| Product NDC: | 0024-2792 |
| Proprietary Name: | Ferrlecit |
| Non Proprietary Name: | sodium ferric gluconate complex |
| Active Ingredient(s): | 12.5 mg/mL & nbsp; sodium ferric gluconate complex |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0024-2792 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020955 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110301 |
| Package NDC: | 0024-2792-10 |
| Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0024-2792-10) > 5 mL in 1 VIAL, SINGLE-USE |
| NDC Code | 0024-2792-10 |
| Proprietary Name | Ferrlecit |
| Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0024-2792-10) > 5 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0024-2792 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sodium ferric gluconate complex |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110301 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | SODIUM FERRIC GLUCONATE COMPLEX |
| Strength Number | 12.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |